{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:07Z","timestamp":1772119747763,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06591"],"award-info":[{"award-number":["21K06591"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K10151"],"award-info":[{"award-number":["22K10151"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11064-023-03902-2","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T18:14:37Z","timestamp":1679854477000},"page":"2230-2240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Glycogen Synthase Kinase-3 Inhibitors Block Morphine-Induced Locomotor Activation, Straub Tail, and Depression of Rearing in Mice Via a Possible Central Action"],"prefix":"10.1007","volume":"48","author":[{"given":"Junichi","family":"Kitanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobue","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Scott","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kento","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"3902_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113506","volume":"415","author":"CA Botz-Zapp","year":"2021","unstructured":"Botz-Zapp CA, Foster SL, Pulley DM, Hempel B, Bi GH, Xi ZX, Newman AH, Weinshenker D, Manvich DF (2021) Effects of the selective dopamine D(3) receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice. Behav Brain Res 415:113506","journal-title":"Behav Brain Res"},{"key":"3902_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173242","volume":"208","author":"NB Varshneya","year":"2021","unstructured":"Varshneya NB, Walentiny DM, Moisa LT, Walker TD, Akinfiresoye LR, Beardsley PM (2021) Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors. Pharmacol Biochem Behav 208:173242","journal-title":"Pharmacol Biochem Behav"},{"key":"3902_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/adb.12538","volume":"23","author":"E Vashchinkina","year":"2018","unstructured":"Vashchinkina E, Piippo O, Vekovischeva O, Krupitsky E, Ilyuk R, Neznanov N, Kazankov K, Zaplatkin I, Korpi ER (2018) Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects. Addict Biol 23:945\u2013958","journal-title":"Addict Biol"},{"key":"3902_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pbb.2018.07.002","volume":"172","author":"N Kitanaka","year":"2018","unstructured":"Kitanaka N, Kitanaka J, Hall FS, Kandori T, Murakami A, Muratani K, Nakano T, Uhl GR, Takemura M (2018) Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex. Pharmacol Biochem Behav 172:9\u201316","journal-title":"Pharmacol Biochem Behav"},{"key":"3902_CR5","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1055\/s-0028-1130858","volume":"37","author":"W Straub","year":"1911","unstructured":"Straub W (1911) Eine empfindliche biologische Reaktion auf Morphin. Deutsche Med Wochenschr 37:1462\u20131468","journal-title":"Deutsche Med Wochenschr"},{"key":"3902_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1476-5381.1969.tb09500.x","volume":"36","author":"MD Aceto","year":"1969","unstructured":"Aceto MD, McKean DB, Pearl J (1969) Effects of opiates and opiate antagonists on the Straub tail reaction in mice. Br J Pharmacol 36:225\u2013239","journal-title":"Br J Pharmacol"},{"key":"3902_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0091-3057(01)00519-6","volume":"69","author":"MR Zarrindast","year":"2001","unstructured":"Zarrindast MR, Alaei-Nia K, Shafizadeh M (2001) On the mechanism of tolerance to morphine-induced Straub tail reaction in mice. Pharmacol Biochem Behav 69:419\u2013424","journal-title":"Pharmacol Biochem Behav"},{"key":"3902_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0014-2999(94)90543-6","volume":"263","author":"C Nath","year":"1994","unstructured":"Nath C, Gupta MB, Patnaik GK, Dhawan KN (1994) Morphine-induced straub tail response: mediated by central mu2-opioid receptor. Eur J Pharmacol 263:203\u2013205","journal-title":"Eur J Pharmacol"},{"key":"3902_CR9","doi-asserted-by":"crossref","unstructured":"Jansen van't Land C, Hendriksen CF (1995) Change in locomotor activity pattern in mice: a model for recognition of distress? Lab Anim 29:286\u2013293","DOI":"10.1258\/002367795781088207"},{"key":"3902_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jphs.2022.03.001","volume":"149","author":"Y Miyazaki","year":"2022","unstructured":"Miyazaki Y, Kobayashi K, Matsushita S, Shimizu N, Murata T (2022) An assessment of the spontaneous locomotor activity of BALB\/c mice. J Pharmacol Sci 149:46\u201352","journal-title":"J Pharmacol Sci"},{"key":"3902_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2012.09.001","volume":"1482","author":"J Kitanaka","year":"2012","unstructured":"Kitanaka J, Kitanaka N, Hall FS, Uhl GR, Tanaka K, Nishiyama N, Takemura M (2012) Straub tail reaction in mice treated with \u03c3(1) receptor antagonist in combination with methamphetamine. Brain Res 1482:40\u201346","journal-title":"Brain Res"},{"key":"3902_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/BF02246982","volume":"110","author":"M Narita","year":"1993","unstructured":"Narita M, Suzuki T, Misawa M, Nagase H (1993) Antagonism of the morphine-induced Straub tail reaction by kappa-opioid receptor activation in mice. Psychopharmacology 110:254\u2013256","journal-title":"Psychopharmacology"},{"key":"3902_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","volume":"12","author":"SW Johnson","year":"1992","unstructured":"Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483\u2013488","journal-title":"J Neurosci"},{"key":"3902_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","volume":"107","author":"N Embi","year":"1980","unstructured":"Embi N, Rylatt DB, Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107:519\u2013527","journal-title":"Eur J Biochem"},{"key":"3902_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.17219\/acem\/62540","volume":"25","author":"K Shin","year":"2016","unstructured":"Shin K, Kim KH, Yoon MS, Suh DS, Lee JY, Kim A, Eo W (2016) Expression of interactive genes associated with apoptosis and their prognostic value for ovarian serous adenocarcinoma. Adv Clin Exp Med 25:513\u2013521","journal-title":"Adv Clin Exp Med"},{"key":"3902_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel E, Grieco SF, Jope RS (2015) Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 148:114\u2013131","journal-title":"Pharmacol Ther"},{"key":"3902_CR17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem 104:1433\u20131439","journal-title":"J Neurochem"},{"key":"3902_CR18","doi-asserted-by":"publisher","first-page":"4209475","DOI":"10.1155\/2019\/4209475","volume":"2019","author":"T Jaworski","year":"2019","unstructured":"Jaworski T, Banach-Kasper E, Gralec K (2019) GSK-3\u03b2 at the intersection of neuronal plasticity and neurodegeneration. Neural Plast 2019:4209475","journal-title":"Neural Plast"},{"key":"3902_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1740-3391-5-3","volume":"5","author":"SA Kaladchibachi","year":"2007","unstructured":"Kaladchibachi SA, Doble B, Anthopoulos N, Woodgett JR, Manoukian AS (2007) Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. J Circadian Rhythms 5:3","journal-title":"J Circadian Rhythms"},{"key":"3902_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0065-230X(02)84007-6","volume":"84","author":"AS Manoukian","year":"2002","unstructured":"Manoukian AS, Woodgett JR (2002) Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res 84:203\u2013229","journal-title":"Adv Cancer Res"},{"key":"3902_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/syn.21642","volume":"67","author":"JC Gandy","year":"2013","unstructured":"Gandy JC, Melendez-Ferro M, Bijur GN, Van Leuven F, Roche JK, Lechat B, Devijver H, Demedts D, Perez-Costas E, Roberts RC (2013) Glycogen synthase kinase-3\u03b2 (GSK3\u03b2) expression in a mouse model of Alzheimer\u2019s disease: a light and electron microscopy study. Synapse 67:313\u2013327","journal-title":"Synapse"},{"key":"3902_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11064-008-9770-1","volume":"34","author":"GN Pandey","year":"2009","unstructured":"Pandey GN, Dwivedi Y, Rizavi HS, Teppen T, Gaszner GL, Roberts RC, Conley RR (2009) GSK-3beta gene expression in human postmortem brain: regional distribution, effects of age and suicide. Neurochem Res 34:274\u2013285","journal-title":"Neurochem Res"},{"key":"3902_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1471-4159.1994.63010245.x","volume":"63","author":"M Takahashi","year":"1994","unstructured":"Takahashi M, Tomizawa K, Kato R, Sato K, Uchida T, Fujita SC, Imahori K (1994) Localization and developmental changes of tau protein kinase I\/glycogen synthase kinase-3 beta in rat brain. J Neurochem 63:245\u2013255","journal-title":"J Neurochem"},{"key":"3902_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0891-0618(99)00012-5","volume":"16","author":"K Leroy","year":"1999","unstructured":"Leroy K, Brion JP (1999) Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat 16:279\u2013293","journal-title":"J Chem Neuroanat"},{"key":"3902_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/00005072-199701000-00007","volume":"56","author":"JJ Pei","year":"1997","unstructured":"Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56:70\u201378","journal-title":"J Neuropathol Exp Neurol"},{"key":"3902_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrn2870","volume":"11","author":"EM Hur","year":"2010","unstructured":"Hur EM, Zhou FQ (2010) GSK3 signalling in neural development. Nat Rev Neurosci 11:539\u2013551","journal-title":"Nat Rev Neurosci"},{"key":"3902_CR27","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1159\/000478873","volume":"42","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Zhu C, Sun B, Lv J, Liu Z, Liu S, Li H (2017) Integrated high throughput analysis identifies GSK3 as a crucial determinant of p53-mediated apoptosis in lung cancer cells. Cell Physiol Biochem 42:1177\u20131191","journal-title":"Cell Physiol Biochem"},{"key":"3902_CR28","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1177\/0269881119836206","volume":"33","author":"M Ucha","year":"2019","unstructured":"Ucha M, Coria SM, N\u00fa\u00f1ez AE, Santos-Toscano R, Roura-Mart\u00ednez D, Fern\u00e1ndez-Ruiz J, Higuera-Matas A, Ambrosio E (2019) Morphine self-administration alters the expression of translational machinery genes in the amygdala of male Lewis rats. J Psychopharmacol 33:882\u2013893","journal-title":"J Psychopharmacol"},{"key":"3902_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2019.107138","volume":"167","author":"Z Fatahi","year":"2020","unstructured":"Fatahi Z, Zeinaddini-Meymand A, Karimi-Haghighi S, Moradi M, Khodagholi F, Haghparast A (2020) Naloxone-precipitated withdrawal ameliorates impairment of cost-benefit decision making in morphine-treated rats: Involvement of BDNF, p-GSK3-\u03b2, and p-CREB in the amygdala. Neurobiol Learn Mem 167:107138","journal-title":"Neurobiol Learn Mem"},{"key":"3902_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S1471-4914(01)02266-3","volume":"8","author":"H Eldar-Finkelman","year":"2002","unstructured":"Eldar-Finkelman H (2002) Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 8:126\u2013132","journal-title":"Trends Mol Med"},{"key":"3902_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s11064-006-9087-x","volume":"31","author":"N Kitanaka","year":"2006","unstructured":"Kitanaka N, Kitanaka J, Takemura M (2006) Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor. Neurochem Res 31:829\u2013837","journal-title":"Neurochem Res"},{"key":"3902_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jpain.2010.06.007","volume":"12","author":"DF Martins","year":"2011","unstructured":"Martins DF, Rosa AO, Gadotti VM, Mazzardo-Martins L, Nascimento FP, Egea J, L\u00f3pez MG, Santos AR (2011) The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice. J Pain 12:315\u2013322","journal-title":"J Pain"},{"key":"3902_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/FBP.0000000000000283","volume":"28","author":"RH Wickens","year":"2017","unstructured":"Wickens RH, Quartarone SE, Beninger RJ (2017) Inhibition of glycogen synthase kinase-3 by SB 216763 affects acquisition at lower doses than expression of amphetamine-conditioned place preference in rats. Behav Pharmacol 28:262\u2013271","journal-title":"Behav Pharmacol"},{"key":"3902_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0014-2999(03)02015-6","volume":"474","author":"N Kitanaka","year":"2003","unstructured":"Kitanaka N, Kitanaka J, Takemura M (2003) Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration. Eur J Pharmacol 474:63\u201370","journal-title":"Eur J Pharmacol"},{"key":"3902_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2012.09.001","volume":"1482","author":"J Kitanaka","year":"2012","unstructured":"Kitanaka J, Kitanaka N, Hall FS, Uhl GR, Tanaka K, Nishiyama N, Takemura M (2012) Straub tail reaction in mice treated with s1 receptor antagonist in combination with methamphetamine. Brain Res 1482:40\u201346","journal-title":"Brain Res"},{"key":"3902_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2021.170734","volume":"150","author":"K Tomita","year":"2022","unstructured":"Tomita K, Yamanishi-Taira S, Igarashi K, Oogai Y, Kuwahara Y, Roudkenar MH, Roushandeh AM, Miyawaki S, Kurimasa A, Sato T (2022) Oxytocin ameliorates KCC2 decrease induced by oral bacteria-derived LPS that affect rat primary cultured cells and PC-12 cells. Peptides 150:170734","journal-title":"Peptides"},{"key":"3902_CR37","first-page":"3207","volume":"18","author":"T Cavalcante Morais","year":"2012","unstructured":"Cavalcante Morais T, Cavalcante Lopes S, Bezerra Carvalho KM, Rodrigues Arruda B, Correia de Souza FT, Salles Trevisan MT, Rao VS, Almeida Santos F (2012) Mangiferin, a natural xanthone, accelerates gastrointestinal transit in mice involving cholinergic mechanism. World J Gastroenterol 18:3207\u20133214","journal-title":"World J Gastroenterol"},{"key":"3902_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12823","volume":"25","author":"KA Porter-Stransky","year":"2020","unstructured":"Porter-Stransky KA, Petko AK, Karne SL, Liles LC, Urs NM, Caron MG, Paladini CA, Weinshenker D (2020) Loss of \u03b2-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids. Addict Biol 25:e12823","journal-title":"Addict Biol"},{"key":"3902_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/jnc.14563","volume":"147","author":"ME Cahill","year":"2018","unstructured":"Cahill ME, Browne CJ, Wang J, Hamilton PJ, Dong Y, Nestler EJ (2018) Withdrawal from repeated morphine administration augments expression of the RhoA network in the nucleus accumbens to control synaptic structure. J Neurochem 147:84\u201398","journal-title":"J Neurochem"},{"key":"3902_CR40","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","volume":"105","author":"R Dajani","year":"2001","unstructured":"Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH (2001) Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105:721\u2013732","journal-title":"Cell"},{"key":"3902_CR41","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/j.1460-2075.1993.tb05715.x","volume":"12","author":"K Hughes","year":"1993","unstructured":"Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J 12:803\u2013808","journal-title":"EMBO J"},{"key":"3902_CR42","doi-asserted-by":"publisher","first-page":"14566","DOI":"10.1016\/S0021-9258(17)36661-9","volume":"269","author":"QM Wang","year":"1994","unstructured":"Wang QM, Fiol CJ, DePaoli-Roach AA, Roach PJ (1994) Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine\/threonine phosphorylation. J Biol Chem 269:14566\u201314574","journal-title":"J Biol Chem"},{"key":"3902_CR43","doi-asserted-by":"crossref","unstructured":"Del'Guidice T, Lemasson M, Beaulieu J-M (2011) Role of beta-Arrestin 2 downstream of dopamine receptors in the Basal Ganglia. Front Neuroanat 5","DOI":"10.3389\/fnana.2011.00058"},{"key":"3902_CR44","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jnc.12258","volume":"125","author":"M Shibasaki","year":"2013","unstructured":"Shibasaki M, Masukawa D, Ishii K, Yamagishi Y, Mori T, Suzuki T (2013) Involvement of the K+\u2013Cl\u2212 co-transporter KCC2 in the sensitization to morphine-induced hyperlocomotion under chronic treatment with zolpidem in the mesolimbic system. J Neurochem 125:747\u2013755","journal-title":"J Neurochem"},{"key":"3902_CR45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/BF02253531","volume":"111","author":"M Narita","year":"1993","unstructured":"Narita M, Suzuki T, Funada M, Misawa M, Nagase H (1993) Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice. Psychopharmacology 111:423\u2013426","journal-title":"Psychopharmacology"},{"key":"3902_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118746","volume":"1867","author":"JL Barr","year":"2020","unstructured":"Barr JL, Unterwald EM (2020) Glycogen synthase kinase-3 signaling in cellular and behavioral responses to psychostimulant drugs. Biochim Biophys Acta Mol Cell Res 1867:118746","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3902_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0166-4328(02)00285-1","volume":"137","author":"JC Horvitz","year":"2002","unstructured":"Horvitz JC (2002) Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behav Brain Res 137:65\u201374","journal-title":"Behav Brain Res"},{"key":"3902_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-4939-9158-7_2","volume":"1957","author":"SA Laporte","year":"2019","unstructured":"Laporte SA, Scott MGH (2019) beta-arrestins: multitask scaffolds orchestrating the where and when in cell signalling. Methods Mol Biol 1957:9\u201355","journal-title":"Methods Mol Biol"},{"key":"3902_CR49","doi-asserted-by":"publisher","first-page":"10265","DOI":"10.1523\/JNEUROSCI.23-32-10265.2003","volume":"23","author":"LM Bohn","year":"2003","unstructured":"Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, Caron MG (2003) Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci 23:10265\u201310273","journal-title":"J Neurosci"},{"key":"3902_CR50","doi-asserted-by":"crossref","unstructured":"Kitanaka J, Kitanaka N, Horie U, Kawasaki Y, Sakamoto T, Yashiro J, Tanaka K, Igarashi K, Tomita K, Shiomoto A, Watabe K, Nakano K, Takahashi H, Nishiyama N, Sato T, Takemura M (2021) Inhibitory effect of SB216763, a selective glycogen synthase kinase-3 inhibitor, on morphine-induced Straub\u2019s tail reaction in mice. Proc Annu Meet Jpn Pharmacol Soc 94:3-P1\u201311","DOI":"10.1254\/jpssuppl.94.0_3-P1-11"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03902-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-023-03902-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03902-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:22:00Z","timestamp":1683865320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-023-03902-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["3902"],"URL":"https:\/\/doi.org\/10.1007\/s11064-023-03902-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2278556\/v1","asserted-by":"object"}]},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that this article content has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal handling and care were conducted in accordance with the <i>Guide for the Care and Use of Laboratory Animals<\/i> (8th edition, Institute of Laboratory Animal Resources-National Research Council, National Academy Press, 2011), and all experiments were reviewed and approved by the Institutional Animal Research Committee of Hyogo Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}